GOLDENWELL BIOTECH INC. (GWLL) Annual Balance Sheets

Annual · GAAP · USD millions
Access GWLL quarterly Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how GOLDENWELL BIOTECH INC. manages its resources, obligations, and shareholder equity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent0.00
Cash & Short-term Investments0.00
Inventories0.17
Total loans net0.01
Total Current Assets0.00
Other Assets, Noncurrent0.04
Total Assets0.04
Liabilities
Accounts Payable0.00
Other Liabilities, Current0.10
Deferred Liability and Revenue0.00
Total Current Liabilities0.10
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.28
Total Liabilities0.38
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1.30
Retained Earnings / Accumulated Deficit-1.66
Common Stockholder's Equity-0.34
Total Stockholder's Equity-0.34
Liabilities & Stockholder's Equity0.04
4 historic quarters locked

Sign in to unlock the full GOLDENWELL BIOTECH INC. balance sheet history.

About Goldenwell Biotech Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: June 30, 2026
  • Source: gdwl_10k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001477932-26-004130

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License